Dr. Copmann holds an Masters degree in Endocrinology, a PhD in Physiology and Post-Doctoral training in Neuroendocrinology. He currently consults for the pharmaceutical industry where he spent over 30 years developing new drugs. He has been active on Editorial Boards, Scientific Advisory boards and as a member of Boards of Directors for multiple companies. He is the former Chair of the Commission on Drugs for Rare Diseases, as well as a former Advisor to the National Vaccine Advisory Board. Dr. Copmann also served as a scientific advisor to the White House.